| 26518090
|
Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. |
J Allergy Clin Immunol |
2015 |
Teach SJ;Gill MA;Togias A;Sorkness CA;Arbes SJ Jr;Calatroni A;Wildfire JJ;Gergen PJ;Cohen RT;Pongracic JA;Kercsmar CM;Khurana Hershey GK;Gruchalla RS;Liu AH;Zoratti EM;Kattan M;Grindle KA;Gern JE;Busse WW;Szefler SJ |
View
More |
| 28608756
|
Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma. |
Am J Respir Crit Care Med |
2017 |
Esquivel A;Busse WW;Calatroni A;Togias AG;Grindle KG;Bochkov YA;Gruchalla RS;Kattan M;Kercsmar CM;Khurana Hershey G;Kim H;Lebeau P;Liu AH;Szefler SJ;Teach SJ;West JB;Wildfire J;Pongracic JA;Gern JE |
View
More |
| 28870461
|
Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab. |
J Allergy Clin Immunol |
2018 |
Gill MA;Liu AH;Calatroni A;Krouse RZ;Shao B;Schiltz A;Gern JE;Togias A;Busse WW |
View
More |
| 32018030
|
Understanding the asthmatic response to an experimental rhinovirus infection: Exploring the effects of blocking IgE. |
J Allergy Clin Immunol |
2020 |
Heymann PW;Platts-Mills TAE;Woodfolk JA;Borish L;Murphy DD;Carper HT;Conaway MR;Steinke JW;Muehling L;Gerald Teague W;Kennedy JL;Irani AM;McGraw MD;Early SV;Wheatley LM;Adams AP;Turner RB |
View
More |
| 32673613
|
Immune responses to rhinoviruses and asthma: Are we 3 steps closer to the door? |
J Allergy Clin Immunol |
2020 |
Gern JE |
View
More |
| 33242697
|
Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation. |
Contemp Clin Trials |
2021 |
Phipatanakul W;Mauger DT;Guilbert TW;Bacharier LB;Durrani S;Jackson DJ;Martinez FD;Fitzpatrick AM;Cunningham A;Kunselman S;Wheatley LM;Bauer C;Davis CM;Geng B;Kloepfer KM;Lapin C;Liu AH;Pongracic JA;Teach SJ;Chmiel J;Gaffin JM;Greenhawt M;Gupta MR;Lai PS;Lemanske RF;Morgan WJ;Sheehan WJ;Stokes J;Thorne PS;Oettgen HC;Israel E |
View
More |
| 35386658
|
Immunoglobulin E-Dependent Activation of Immune Cells in Rhinovirus-Induced Asthma Exacerbation. |
Front Allergy |
2022 |
Kawakami T;Kasakura K;Kawakami Y;Ando T |
View
More |
| 36644451
|
Omalizumab may protect allergic patients against COVID-19: A systematic review. |
World Allergy Organ J |
2023 |
Ghiglioni DG;Cozzi EL;Castagnoli R;Bruschi G;Maffeis L;Marchisio PG;Marseglia GL;Licari A |
View
More |
